New Alzheimer’s Drug, New Controversy
![album-art](https://podcasts.federatedmedia.com/wp-content/themes/sonaar/images/defaultpx.png)
FDA approval of Aduhelm for early stage Alzheimer’s is both a huge breakthrough and controversy. HealthCall’s Lee Kelso explains why this drug raises issues that affect every American family one way or the other.
See omnystudio.com/listener for privacy information.